Inhibrx Biosciences (INBX) EPS (Diluted) (2023 - 2025)
Inhibrx Biosciences (INBX) EPS (Diluted) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 0.15 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 4.02 |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 6.75 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | 0.00 |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 7.33 |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | -2.29 |
| 10 | Inhibrx Biosciences | 1.27 Bn | 1.27 Bn | - | -2.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.12 |
| Sep 30, 2025 | -2.28 |
| Jun 30, 2025 | -1.85 |
| Mar 31, 2025 | -2.80 |
| Dec 31, 2024 | -3.19 |
| Sep 30, 2024 | -2.84 |
| Jun 30, 2024 | 125.48 |
| Mar 31, 2024 | -5.77 |
| Dec 31, 2023 | -7.81 |
| Sep 30, 2023 | -4.39 |
| Jun 30, 2023 | -4.31 |